AstraZeneca: Vaccine prompts immune response in elderly
British drugmaker AstraZeneca said on Monday that its coronavirus vaccine candidate being developed by the University of Oxford produces an immune response in both younger and older adults.
Sign Up for Mideast Daily News
Wake up to the Trusted Mideast News source
By subscribing, you agree to The Media Line terms of use and privacy policy.